Sarsia is an early statge venture capital investor based in Bergen, Norway. We invest in science based technology companies within energy/cleantech and biotechnology/life science. Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors. Sarsia Seed Fund I has been operational since 2007 and contains 22 investments, 5 Exits, one IPO and 14 portfoliocompanies. Sarsia Seed Fund II has been operational since Summer 2017 and has made two investments.